Coronalolide
CAS: 268214-51-3
Ref. 3D-TKA21451
1mg | Nachfragen | |
5mg | Nachfragen | |
10mg | Nachfragen | |
25mg | Nachfragen | |
50mg | Nachfragen |
Produktinformation
- (3R,3aR,5aS,6aR,6bR,9aR,10aS,10bS)-3-[(1R,4E)-1,5-Dimethyl-6-oxo-4-hexen-1-yl]tetradecahydro-3a,10b-dimethyl-7-methylene-8-oxo-6aH-cyclopenta[7,8]cyclopropa[4,4a]naphtho[2,3-b]furan-6a-propanoic acid
- 10bH-Cyclopenta[7,8]cyclopropa[4,4a]naphtho[2,3-b]furan-10b-propanoic acid, 4-[(1R,4E)-1,5-dimethyl-6-oxo-4-hexenyl]tetradecahydro-3a,6a-dimethyl-10-methylene-9-oxo-, (1aS,3aR,4R,6aS,6bS,7aR,10aR,10bR)-
- 6aH-Cyclopenta[7,8]cyclopropa[4,4a]naphtho[2,3-b]furan-6a-propanoic acid, 3-[(1R,4E)-1,5-dimethyl-6-oxo-4-hexen-1-yl]tetradecahydro-3a,10b-dimethyl-7-methylene-8-oxo-, (3R,3aR,5aS,6aR,6bR,9aR,10aS,10bS)-
Coronalolide is a rubiaceous plant that has been shown to have a blood pressure lowering effect. It inhibits angiotensin II-induced elevation of blood pressure and also reduces the activity of the enzyme agalactiae, which is responsible for the production of angiotensin II. Coronalolide has been shown to be active against a wide range of organisms, including bacteria and fungi. Coronalolide is also an antibacterial agent and has demonstrated antibacterial activity in vivo in an animal model. This compound also has modulating effects on cancer cells by inhibiting tumorigenesis and proliferation of endothelial cells and may be useful for the treatment of neurodegenerative diseases such as Alzheimer's disease.
Chemische Eigenschaften
Technische Anfrage zu: 3D-TKA21451 Coronalolide
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.